Journal of Natural Products
ARTICLE
resolved by HPLC to yield 2 (3 mg) and 3 (9 mg). Fraction F (1.2 g) was
separated by RP-18 CC (MeOH/H2O, 3:7ꢀ9:1) and further purified
by silica gel CC (CHCl3/MeOH, 40:1ꢀ5:1) to give 1 (31 mg) and
gardneramine-N(4)-oxide (46 mg).
Cytotoxicity Assay. The cytotoxicity assay was performed accord-
ing to the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide] method,21 by use of the following five human cancer
cell lines: breast cancer MCF-7, hepatocellular carcinoma SMMC-
7721, human myeloid leukemia HL-60, colon cancer SW480, and lung
cancer A-549 cells, and IC50 values were calculated by Reed and
Muench’s method.22
Gardfloramine-9-O-β-D-glucopyranoside (1): white needles
(MeOH); mp 207ꢀ208 °C; [R]24 ꢀ252.8 (c 0.13, MeOH); UV
D
(MeOH) λmax (log ε) 295 (0.91), 233 (3.43) nm; IR (KBr) νmax 3415,
2897, 1583, 1459, 1346, 1073 cmꢀ1 1H (500 MHz) and 13C
;
NMR (100 MHz) data (MeOH-d4), see Tables 1 and 3, respec-
tively; HREIMS m/z 544.2079 (calcd for C27H32N2O10 [M]þ,
544.2057).
’ ASSOCIATED CONTENT
S
Supporting Information. 1D and 2D NMR and HREIMS
b
19(E)-18-Demethoxygardfloramine-N(4)-oxide (2): yellow
oil; [R]24D ꢀ125.9 (c 0.14, MeOH); UV (MeOH) λmax (log ε) 296
(0.07), 240 (0.42), 203 (0.43), 196 (0.31) nm; IR (KBr) νmax 3424,
spectra of compounds 1ꢀ8. These materials are available free of
1
2920, 1622, 1587, 1449, 1349, 1050 cmꢀ1; H (500 MHz) and 13C
NMR (125 MHz) data (MeOH-d4), see Tables 1 and 3, respec-
tively; HREIMS m/z 382.1530 (calcd for C21H22N2O5 [M]þ,
382.1529).
’ AUTHOR INFORMATION
Corresponding Author
*Tel: þ86-871-5223177. Fax: þ86-871-5150227. E-mail: xdluo@
Gardfloramine-N(4)-oxide (3): yellow oil; [R]24D ꢀ232.3 (c 0.11,
MeOH); UV (MeOH) λmax (logε) 307 (0.88), 298 (0.87), 229 (3.97) nm;
mail.kib.ac.cn.
1
IR (KBr) νmax 3425, 2927, 1624, 1588, 1451, 1348, 1045 cmꢀ1; H
(400 MHz) and 13C NMR (100 MHz) data (MeOH-d4), see Tables 1 and
3, respectively; HREIMS m/z 412.1642 (calcd for C22H24N2O6 [M]þ,
412.1634).
’ ACKNOWLEDGMENT
The authors are grateful to the National Basic Research Program
of China (973 Program 2009CB522300), Chinese Academy of
Sciences (KSCX2-YW-R-202 and KSCX2-EW-R-15), and the
National Natural Science Foundation of China for partial financial
support.
18-Demethylgardfloramine (4): yellow oil; [R]25 ꢀ270.4
D
(c 0.12, MeOH); UV (MeOH) λmax (log ε) 295 (0.81), 237
(3.64) nm; IR (KBr) νmax 3422, 2926, 1622, 1575, 1449, 1344,
1052, 751 cmꢀ1; 1H (500 MHz) and 13C NMR (125 MHz) data (MeOH-
d4), see Tables 1 and 3, respectively; HREIMS m/z 382.1535 (calcd for
C21H22N2O5 [M]þ, 382.1529).
19(E)-9,18-Didemethoxygardneramine (5): yellow oil; [R]25
’ REFERENCES
D
ꢀ333.2 (c 0.12, MeOH); UV (MeOH) λmax (log ε) 375 (0.01), 314
(1) Bonjoch, J.; Solꢀe, D. Chem. Rev. 2000, 100, 3455–3482.
(2) O’Connor, S. E.; Maresh, J. J. Nat. Prod. Rep. 2006, 23, 532–547.
(3) Frꢀedꢀerich, M.; Jacquier, M. J.; Thꢀepenier, P.; De Mol, P.; Tits,
M.; Philippe, G.; Delaude, C.; Angenot, L.; Zꢀeches-Hanrot, M. J. Nat.
Prod. 2002, 65, 1381–1386.
(4) Cai, X. H.; Du, Z. Z.; Luo, X. D. Org. Lett. 2007, 9, 1817–1820.
(5) Feng, T.; Cai, X. H.; Li, Y.; Wang, Y. Y.; Liu, Y. P.; Xie, M. J.; Luo,
X. D. Org. Lett. 2009, 11, 4834–4837.
(6) Feng, T.; Li, Y.; Liu, Y. P.; Cai, X. H.; Wang, Y. Y.; Luo, X. D. Org.
Lett. 2010, 12, 968–971.
(7) Cai, X. H.; Tan, Q. G.; Liu, Y. P.; Feng, T.; Du, Z. Z.; Li., W. Q.;
Luo, X. D. Org. Lett. 2008, 10, 577–580.
(8) Feng, T.; Cai, X. H.; Zhao, P. G.; Du, Z. Z.; Li., W. Q.; Luo, X. D.
Planta Med. 2009, 75, 1537–1541.
(9) Feng, T.; Li, Y.; Cai, X. H.; Gong, X.; Liu, Y. P.; Zhang, R. T.;
Zhang, X. Y.; Tan, Q. G.; Luo, X. D. J. Nat. Prod. 2009, 72, 1836–1841.
(10) Feng, T.; Cai, X. H.; Liu, Y. P.; Li, Y.; Wang, Y. Y.; Luo, X. D.
J. Nat. Prod. 2010, 73, 22–26.
(11) Feng, T.; Li, Y.; Wang, Y. Y.; Cai, X. H.; Liu, Y. P.; Luo, X. D.
J. Nat. Prod. 2010, 73, 1075–1079.
(12) Haginiwa, J.; Sakai, S.; Kubo, A.; Takahashi, K.; Taguchi, M.
Yakugaku Zasshi 1970, 90, 219–223.
(13) Sakai, S.; Aimi, N.; Yamaguchi, K.; Ogata, K.; Haginiwa, J.
Chem. Pharm. Bull. 1987, 35, 453–455.
(0.72), 272 (1.32), 228 (3.44) nm; IR (KBr) νmax 3432, 2933, 1579, 1474,
1
1280, 1080, 822 cmꢀ1; H (400 MHz) and 13C NMR (125 MHz) data
(MeOH-d4), see Tables 2 and 3, respectively; HREIMS m/z 352.1797 (calcd
for C21H24N2O3 [M]þ, 352.1787).
19(E)-11-Methoxy-9,18-didemethoxygardneramine (6):
colorless needles (MeOH); mp 102ꢀ104 °C; [R]24D ꢀ135.7 (c 0.20,
MeOH); UV (MeOH) λmax (log ε) 279 (0.82), 233 (3.50), 206
(2.25) nm; IR (KBr) νmax 3426, 2942, 1576, 1472, 1344, 1119,
1049 cmꢀ1; 1H (500 MHz) and 13C NMR (100 MHz) data (MeOH-
d4), see Tables 2 and 3, respectively; HREIMS m/z 382.1902 (calcd for
C22H26N2O4 [M]þ, 382.1893).
9-Demethoxy-18-demethylgardneramine (7): yellow oil;
[R]24 ꢀ349.1 (c 0.09, MeOH); UV (MeOH) λmax (log ε) 312
D
(0.41), 272 (0.81) 227 (2.40), 207 (2.20) nm; IR (KBr) νmax 3424,
2928, 1577, 1467, 1296, 1074 cmꢀ1; 1H (400 MHz) and 13C NMR (100
MHz) data (MeOH-d4), see Tables 2 and 3, respectively; HREIMS m/z
368.1737 (calcd for C21H24N2O4 [M]þ, 368.1736).
Minfiensine-N(4)-oxide (8): yellow oil; [R]25 þ183.4 (c 0.10,
D
MeOH); UV (MeOH) λmax (log ε) 360 (0.04), 292 (1.02), 236 (2.09),
215 (2.99), 193 (0.87) nm; IR (KBr) νmax 3407, 2920, 1609, 1468, 1127,
750 cmꢀ1; 1H (400 MHz) and 13C NMR (100 MHz) data (MeOH-d4),
see Tables 2 and 3, respectively; HREIMS m/z 310.1675 (calcd for
C19H22N2O2 [M]þ, 310.1681).
(14) Sakai, S.; Aimi, N.; Yamaguchi, K.; Ohhira, H.; Hori, K.;
Haginiwa, J. Tetrahedron Lett. 1975, 16, 715–718.
Acid Hydrolysis of 1. Compound 1 (5 mg) was refluxed with 2 M
HCl/MeOH (1:1, 10 mL) for 6 h at 60 °C. The reaction mixture was
evaporated to dryness and diluted with H2O (5 mL). After extraction
with EtOAc (3 ꢁ 5 mL), the aqueous layer was concentrated. The
residue was identified as glucose by comparison with an authentic
sample using TLC (CHCl3/MeOH/H2O, 6:4:1; Rf = 0.3). Purification
of the aqueous layer was performed by Sephadex LH-20 CC (MeOH)
followed by silica gel CC (CHCl3/MeOH/H2O, 3:1:0.1) to afford
D-glucose with a specific rotation [R]24D þ53.2 (c 0.24, H2O).
(15) Sakai, S.; Aimi, N.; Kubo, A.; Kitagawa, M.; Shiratori, M.;
Haginiwa, J. Tetrahedron Lett. 1971, 12, 2057–2060.
(16) Sakai, S.; Aimi, N.; Kubo, A.; Kitagawa, M.; Hanasawa, M.;
Katano, K.; Yamaguchi, K.; Haginiwa, J. Chem. Pharm. Bull. 1975,
23, 2805–2817.
(17) Aimi, N.; Sakai, S.; Iitaka, Y.; Itai, A. Tetrahedron Lett. 1971,
12, 2061–2064.
(18) Aimi, N.; Yamaguchi, K.; Sakai, S.; Haginiwa, J.; Kubo., A.
Chem. Pharm. Bull. 1978, 26, 3444–3449.
1077
dx.doi.org/10.1021/np2000254 |J. Nat. Prod. 2011, 74, 1073–1078